Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: A prospective cohort study

Pediatric Infectious Disease Journal

Volumn 26, Issue 8, 2007, Pages 700-704

  Ramphal, Raveena ^a   Grant, Ronald M ^a   Dzolganovski, Biljana ^a   Constantin, Julie ^a   Tellier, Raymond ^a   Allen, Upton ^a   Weitzman, Sheila ^a   Matlow, Anne ^a   Petric, Martin ^a   Sung, Lillian ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Febrile neutropenia; Herpes simplex virus; Persistent fever

Indexed keywords

ACICLOVIR; ANTIINFECTIVE AGENT; CEFTAZIDIME; GENTAMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE DURATION; FEBRILE NEUTROPENIA; FEMALE; FEVER; HERPES SIMPLEX VIRUS; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH EXAMINATION; MUCOSA INFLAMMATION; NEUTROPENIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT RESPONSE; VIRUS INFECTION;

ADOLESCENT; ANTI-INFECTIVE AGENTS; BLOOD; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA, VIRAL; FEMALE; FEVER; HERPES SIMPLEX; HUMANS; INFANT; MALE; MOUTH; MUCOSITIS; NEOPLASMS; NEUTROPENIA; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; SIMPLEXVIRUS;

EID: 34548722241     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e31805cdc11     Document Type: Article

References (15)

1. Pizzo PA, Robichaud KJ, Wesley R, Commers JR. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine. 1982;61:153-165.
2. Glauser M; for International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Hann I, Viscoli C, Paesmans M, Gaya H, A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. Br J Haematol. 1997;99:580-588.
3. Zinner SH; for The EORTC International Antimicrobial Therapy Project Group. Schimpff SC, Gaya H, Klastersky J, Tattersall MH, Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis. 1978;137:14-29.
4. Granowetter L, Wells H, Lange BJ. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient. Pediatr Infect Dis J. 1988;7:165-170.
5. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med. 1989;86:668-672.
6. Prober CG. Herpes simplex virus. New York: Churchill Livingstone Inc.; 1997.
7. Baglin TP, Gray JJ, Marcus RE, Wreghitt TG. Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy. J Clin Pathol. 1989;42:1255-1258.
8. Lonnqvist B, Palmblad J, Ljungman P, et al; for The Leukemia Group of Middle Sweden. Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. Support Care Cancer. 1993;1:139-144.
9. Ringden O, Heimdahl A, Lonnqvist B, Malmborg AS, Wilczek H. Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet. 1984;1:744.
10. Hann IM, Prentice HG, Blacklock HA, et al. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J. 1983;287:384-388.
11. Johnson G, Nelson S, Petric M, Tellier R. Comprehensive PCR-based assay for detection and species identification of human herpesviruses. J Clin Microbiol. 2000;38:3274-3279.
12. Muller SA, Herrmann EC Jr, Winkelmann RK. Herpes simplex infections in hematologic malignancies. Am J Med. 1972;52:102-114.
13. Viscoli C, Bruzzi P, Glauser M. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients. Eur J Cancer. 1995;31A:2013-2022.
14. Carrega G, Castagnola E, Canessa A, et al. Herpes simplex virus and oral mucositis in children with cancer. Support Care Cancer. 1994;2:266-269.
15. Loutfy SA, Alam El-Din HM, Ibrahim MF, Hafez MM. Seroprevalence of herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus in children with acute lymphoblastic leukemia in Egypt. Saudi Med J. 2006;27:1139-1145.